Brian Jacobson, MD, MPH, the director of program development for gastroenterology at Massachusetts General Hospital, in Boston, sat down with GEN at DDW 2024 to discuss new research from “a wonderful session” on endoscopic retrograde cholangiopancreatography, presented by a “real who’s who of ERCP.”
Dr. Jacobson discussed presentations on post-ERCP pancreatitis and a promising new risk stratification tool to better identify patients at risk for this common complication.
He also explained the growing role of endoscopic-guided ultrasound (EUS) and other newer techniques in this setting. “When you have a patient that you cannot get access to for your ERCP, there’s no reason now we should not be going to EUS therapeutic procedures first.” This has become the standard of care, he added, noting that EUS is better tolerated by patients than percutaneous drainage.
—GEN News Staff